I was pretty excited about the announcements before and during the Mobile World Congress in Barcelona last week. Android was the star of the show, with many many manufacturers showing off hardware that uses the operating system. Forefront in the hype was the tablet-specific iteration, called Honeycomb that will be available on many of the […]Read More Motorola Xooms itself in the foot?
Here’s my final post on the #DigiPharm narrative. Part 7! Again, I am reporting on selected sessions from Day 2, ones that I found of note or interest. You can read the twitterstream for more information on the presentations not covered here. Part 1 Part 2 Part 3 Part 4 Part 5 Part 6 Still […]Read More DigiPharm Europe 2010 Pt 7
So here’s the penultimate part of this week-long series. Today I am focusing on the morning session of Day 2 of DigiPharm 2010 and the concluding blog post tomorrow will cover the afternoon session. I will not cover every presentation from Day 2, just the ones that had impact with the audience. Part 1 Part […]Read More DigiPharm Europe 2010 Pt 6
Once more unto the DigiPharm breach. Part 1 Part 2 Part 3 Part 4 Part 6 Part 7 Building up to reportable adverse events When last we spoke, I covered patient community discussions. We now turn our attention to reportable adverse events and the Internet presented by Daniel Ghinn and Paul Grant. They start by […]Read More DigiPharm Europe 2010 Pt 5
And to the next instalment of this series on DigiPharm Europe 2010. Part 1 Part 2 Part 3 Part 5 Part 6 Part 7 When is a community not a community? The session entitled “Community management in Pharma” was presented by René Vvan den Bos and Erik Van der Zijden. They focused on mythical ailment […]Read More DigiPharm Europe 2010 Pt 4